Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05020535 · ClinicalTrials.gov registry record · Phase 2

Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)

A Phase 2 study of Intracerebral Hemorrhage, sponsored by Johns Hopkins University.

Recruiting
Registry status
Phase 2
Development phase
120
Enrollment target
11
Study locations

NCT05020535: Recruiting Phase 2 study of Intracerebral Hemorrhage, sponsored by Johns Hopkins University.

NCT05020535 is a Phase 2 study of Intracerebral Hemorrhage that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 120 participants, below the 1,172-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (90% lower). The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05020535, a Phase 2 study of Intracerebral Hemorrhage, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
Phase 2
Development phase
120 participants
Enrollment target
11
Study locations

Study Summary

This first-in-patient phase 2a pilot study will assess the safety and tolerability of MW01-6-189WH (hereafter called MW189) in patients with Intracerebral Hemorrhage (ICH).

Conditions Studied

Intracerebral Hemorrhage

Interventions

  • OTHER Saline
  • DRUG MW189

Study Locations (11)

Texas

  • University of Texas Houston - Houston
  • University of Texas San Antonio - San Antonio

Alabama

  • University of Alabama Birmingham - Birmingham

California

  • Stanford University - Palo Alto

Connecticut

  • Yale New Haven Hospital - New Haven

Florida

  • Cleveland Clinic Florida - Stuart

Kentucky

  • University of Kentucky - Lexington

Maryland

  • Johns Hopkins Hospital - Baltimore

New Mexico

  • University of New Mexico - Albuquerque

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2022-10-10
Est. Completion 2027-10-01
Phase Phase 2

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05020535

The ClinicalTrials.gov registry entry for NCT05020535 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,172-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (90% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.

NCT05020535 reports 11 study locations spanning 10 distinct geographic areas - top geographies include Texas, Alabama, California.

Frequently Asked Questions

What is clinical trial NCT05020535 about?

NCT05020535 is a clinical study titled "Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)". This first-in-patient phase 2a pilot study will assess the safety and tolerability of MW01-6-189WH (hereafter called MW189) in patients with Intracerebral Hemorrhage (ICH).

What is the current status of trial NCT05020535?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2022-10-10. Estimated completion is 2027-10-01.

What conditions does trial NCT05020535 study?

This clinical trial studies the following conditions: Intracerebral Hemorrhage.

What interventions are being tested in trial NCT05020535?

The interventions under investigation include: Saline (OTHER), MW189 (DRUG).

Who is sponsoring clinical trial NCT05020535?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05020535 being conducted?

This trial has 11 study locations across Alabama, California, Connecticut, Florida, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Intracerebral Hemorrhage

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Intracerebral Hemorrhage

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.